Phase IIa (PoCP) trial in UC
Research payments
$21,418
Through program year 2024, $21,418 in research payments was reported against Phase IIa (PoCP) trial in UC, across 8 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $21,418 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bhaktasharan Patel Colorado Springs, CO Named on 1 payment
- Jonathan Rosenberg Gurnee, IL Named on 1 payment
- Manuel Rodriguez Bradenton, FL Named on 1 payment
- Ryan Cho Cedar Park, TX Named on 1 payment
- Ramses Vega Miami, FL Named on 1 payment
- Suwebatu Odunsi Shiyanbade Mansfield, TX Named on 1 payment
- Tuba Esfandyari Kansas City, KS Named on 1 payment
- William Holderman Tacoma, WA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.